Top Markets
Coin of the day
Medicure Inc. Medicure Inc.

Medicure Inc.

MPH
Classement en actions #32234
Medicure Inc. is a biopharmaceutical firm focused on developing, researching,... Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.
Prix de l'action
$1.02
Capitalisation boursière
$10.65M
Changement (1 jour)
2.21%
Changement (1 an)
22.59%
Pays
CA
Échange Medicure Inc. (MPH)

Catégorie

Historique des divisions d’actions pour Medicure Inc. (MPH)
L’action Medicure Inc. (symbole : MPH) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 18, 2026.
Une action MPH achetée avant le Aug 18, 2026 équivaudrait aujourd’hui à 0 actions MPH.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes